Acer Therapeutics Inc. (36) | Uncategorized (6)

Recent Contracts

Synthetic Royalty Agreement dated March 4, 2022, between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P (Filed With SEC on March 7, 2022)
Second Amendment, dated November 17, 2021, by and between Acer Therapeutics Inc. and Eastern Western Corp (Filed With SEC on March 2, 2022)
Agreement of Access and Use of Clinical Trial Data, dated as of August 3, 2016, by and between LAssistance Publique Hpitaux de Paris and Acer Therapeutics Inc (Filed With SEC on August 10, 2021)
First Amendment, dated April 23, 2019, by and between Acer Therapeutics Inc. and Eastern Western Corp (Filed With SEC on August 10, 2021)
Option Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Securities Purchase Agreement, dated July 24, 2020, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto (Filed With SEC on July 27, 2020)